Search Results

Bupropion and naltrexone: a review of their use individually and in combination for the treatment of obesity

Authors: Plodkowski, Raymond A; Nguyen, Quang; Sundaram, Umasankari; Nguyen, Loida; Chau, Diane L; St Jeor, Sachiko

Source: Expert Opinion on Pharmacotherapy, Volume 10, Number 6, April 2009 , pp. 1069-1081(13)

Publisher: Informa Healthcare

A Preliminary Trial: Double-Blind Comparison of Nefazodone, Bupropion-SR, and Placebo in the Treatment of Cannabis Dependence

Authors: Carpenter, Kenneth; McDowell, David; Brooks, Daniel; Cheng, Wendy; Levin, Frances

Source: American Journal on Addictions, Volume 18, Number 1, January 2009 , pp. 53-64(12)

Publisher: Informa Healthcare

A cost-effectiveness analysis of genetic testing of the DRD2 Taq1A polymorphism to aid treatment choice for smoking cessation

Authors: Welton, Nicky; Johnstone, Elaine; David, Sean; Munafo, Marcus

Source: Nicotine & Tobacco Research, Volume 10, Number 1, 2008 , pp. 231-240(10)

Publisher: Informa Healthcare

A randomized trial of short psychotherapy versus sustained-release bupropion for smoking cessation

Authors: Zernig, Gerald; Wallner, Reinhild; Grohs, Ursula; Kriechbaum, Norbert; Kemmler, Georg; Saria, Alois

Source: Addiction, Volume 103, Number 12, December 2008 , pp. 2024-2031(8)

Publisher: Blackwell Publishing

Psychological mediators of bupropion sustained-release treatment for smoking cessation

Authors: McCarthy, Danielle E.; Piasecki, Thomas M.; Lawrence, Daniel L.; Jorenby, Douglas E.; Shiffman, Saul; Baker, Timothy B.

Source: Addiction, Volume 103, Number 9, September 2008 , pp. 1521-1533(13)

Publisher: Blackwell Publishing

Extended cognitive behavior therapy for cigarette smoking cessation

Authors: Killen, Joel D.; Fortmann, Stephen P.; Schatzberg, Alan F.; Arredondo, Christina; Murphy, Greer; Hayward, Chris; Celio, Maria; Cromp, DeAnn; Fong, Dalea; Pandurangi, Maya

Source: Addiction, Volume 103, Number 8, August 2008 , pp. 1381-1390(10)

Publisher: Blackwell Publishing

Spotlight on Bupropion in Major Depressive Disorder

Authors: Dhillon, Sohita; Yang, Lily P.H.; Curran, Monique P.

Source: CNS Drugs, Volume 22, Number 7, 2008 , pp. 613-617(5)

Publisher: Adis International

Smoking and Weight

Author: Hymowitz, Norman

Source: Current Respiratory Medicine Reviews, Volume 4, Number 2, May 2008 , pp. 137-149(13)

Publisher: Bentham Science Publishers

Effect of varenicline and bupropion SR on craving, nicotine withdrawal symptoms, and rewarding effects of smoking during a quit attempt

Authors: West, Robert; Baker, Christine; Cappelleri, Joseph; Bushmakin, Andrew

Source: Psychopharmacology, Volume 197, Number 3, April 2008 , pp. 371-377(7)

Publisher: Springer

Bupropion: A Review of its Use in the Management of Major Depressive Disorder

Authors: Dhillon, Sohita; Yang, Lily P.H.; Curran, Monique P.

Source: Drugs, Volume 68, Number 5, 2008 , pp. 653-689(37)

Publisher: Adis International

Predictors of 12-Month Outcome in Smokers Who Received Bupropion Sustained-Release for Smoking Cessation

Authors: Swan, Gary E.; Jack, Lisa M.; Javitz, Harold S.; McAfee, Tim; McClure, Jennifer B.

Source: CNS Drugs, Volume 22, Number 3, 2008 , pp. 239-256(18)

Publisher: Adis International

Bupropion/zonisamide SR has potential in obesity

Source: Inpharma, Volume 1, Number 1620, 2008-01-12 , pp. 20-20(1)

Publisher: Adis International

Bupropion SR effective for smoking cessation in primary care

Source: Inpharma, Volume 1, Number 1614, 2007-11-17 , pp. 19-19(1)

Publisher: Adis International

Successfully Treating Nicotine Dependence

Author: Glover, Elbert D.

Source: American Journal of Health Education, Volume 37, Number 1, January/February 2006 , pp. 6-14(9)

Publisher: American Alliance for Health, Physical Education, Recreation & Dance

Review of the Pharmacology and Clinical Profile of Bupropion, an Antidepressant and Tobacco Use Cessation Agent

Authors: Dwoskin, Linda P.; Rauhut, Anthony S.; King-Pospisil, Kelley A.; Bardo, Michael T.

Source: CNS Drug Reviews, Volume 12, Numbers 3-4, Fall/Winter 2006 , pp. 178-207(30)

Publisher: Blackwell Publishing

Partial agonism at nicotinic receptors with varenicline - a new approach to smoking cessation

Author: Doggrell, Sheila A

Source: Expert Opinion on Pharmacotherapy, Volume 7, Number 18, December 2006 , pp. 2599-2603(5)

Publisher: Informa Healthcare

Varenicline: A Review of its Use as an Aid to Smoking Cessation Therapy

Authors: Keating, Gillian M.; Siddiqui, M. Asif A.

Source: CNS Drugs, Volume 20, Number 11, 2006 , pp. 945-960(16)

Publisher: Adis International

Bupropion SR appears to be the most cost-effective smoking cessation therapy compared with nortriptyline and placebo

Source: PharmacoEconomics and Outcomes News, Volume 1, Number 514, 2006-10-21 , pp. 8-8(1)

Publisher: Adis International

Bupropion SR appears to be the most cost-effective smoking cessation therapy compared with nortriptyline and placebo

Source: Inpharma, Volume 1, Number 1560, 2006-10-21 , pp. 5-5(1)

Publisher: Adis International

Both bupropion sustained release (SR) and naltrexone exhibit similar efficacy in patients with pathological gambling

Source: Inpharma, Volume 1, Number 1521, 2006-01-21 , pp. 11-11(1)

Publisher: Adis International